State of clinical research of radiotherapy/chemoradiotherapy and immune checkpoint inhibitor therapy combinations in solid tumours —a German radiation oncology survey

Combinations of immune checkpoint inhibitors (ICIs) with radiotherapy and/or chemoradiotherapy are currently under investigation in many cancer types and clinical settings. In this survey, we solicited members of the German Radiation Oncology Society and young DEGRO (working group of DEGRO e.V.) to review the current status of research in this field and underline critical issues such as oncological benefit, treatment toxicity and obstacles in clinical research. The responses represent 14 different departments of radiation oncology at German university hospitals.

Source: European Journal of Cancer - January 14, 2019 Category: Cancer & Oncology Authors: Lukas K äsmann, Chukwuka Eze, Maurice Dantes, Olarn Roengvoraphoj, Maximilian Niyazi, Claus Belka, Farkhad Manapov Tags: Current Perspective Source Type: research